维普中文期刊产品整合服务
46篇 您的检索式:作者名="BIBLE J"
    题名 作者 年代 出处 被引量
1Genetic evolu- tion of enterovirus 71 : epidemiological and pathological implica- tions 显示文摘BIBLE J M PANTELIDIS P CHAN P K 2007Rev Med Virol2007,17,6:1
2Genetic evolution of enterovirus 71:epidemiological and pathological implications显示文摘Bible J M Pantelidis P Chan P K 2007Rev Med Virol2007,17,:1
3Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study显示文摘Keith C Bible Vera J Suman Julian R Molina Robert C Smallridge William J Maples Michael E Menefee Joseph Rubin Kostandinos Sideras John C Morris Bryan McIver Jill K Burton Kevin P Webster Carolyn Bieber Anne M Traynor Patrick J Flynn Boon Cher Goh Hui Tan 2010Lancet Oncology2010,,10:1
4Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with-low and high-CSF A beta 40 load显示文摘Wiltfang J Esselmann H Bibl M 2007J Neurochem2007,101,4:1
5Genetic evolution of enterovirus 71 : Epidemiological and pathological implications 显示文摘Bible J M Pantelidis P Chart P K 2007Rev Med Virol2007,17,6:1
6Molectdar epidemiology of hurmn entemvims 71 in the United Kingdom from 1998 to 2006显示文摘Bible J M Itmriza-Gorrkara M Megson B 2008J Clin Microbiol2008,46,10:1
7Loss of expression of a new member of the DIVA,protein family confers resistance to chernotherapeutic agents used in the treatment of ovarian cancer显示文摘Shridhar V Bible KC Staub J 2001Cancer Res2001,61,10:1
8Molec-ular Epidemiology of Human Enterovirus 71in the Unit-ed Kingdom from 1998to 2006显示文摘Bible J M Iturriza-Gomara M Megson B 2008Clin Microbiol2008,46,10:1
9Amyloid beta peptide ratio 42/40 but not AI3 42 corelates with phospho-Tau in patients with low- and high-CSF AI340 load 显示文摘Wilffang J Esselmann H Bibl M 2007Neurochem2007,101,4:1
10Analysis versus dual-rincision fasciotomy for tibial of single-incision fractures with a- cute compartment syndrome 显示文摘Bible JE McClure D J Mir HR 2013J Orthop Trauma2013,27,11:1
11Efficacy of pazopanib in progres- sive, radioiodine-refractory, metastatic differentiated thyroid cancers : re- sults of aphase 2 consortium study显示文摘Bible KC Suman V J Molina JR 2010Lancet Oncol2010,11,10:1
12Quantification of bony pelvic exposure through the modified Stoppa approach显示文摘Bible J E Choxi A A Kadakia R J 2014J Orthop Trauma2014,28,6:1
13Genetic evolution ofenterovirus 71:epidemiological and pathological implications显示文摘Bible J M Pantelidis P Chan P K 2007Rev Med Virol2007,17,6:1
14Molecular epide-miology of human enterovirus 71 in the United Kingdom from 1998to 2006显示文摘Bible J M Iturriza-Gomara M Megson B 2008J Clin Microbiol2008,46,10:1
15Genetic evolu- tion of enterovirus 71: epidemiological and pathological implications 显示文摘Bible J M Pantelidis P Chan P K 2007Rev Med Virol2007,17,6:1
16Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006显示文摘Bible J M It urriza G M Megson B et a1 2008J Clin Microbiol2008,46,10:1
17Phase Ⅰ trial of flavopiridol combined with cisplatin or carboplatin in patients with advanced malignancies with the assessment of pharmacokinetic and pharmacodynamic end points 显示文摘BIBLE K C LENSING J L NELSON S A 2005Clin Cancer Res2005,11,16:1
18Efficacy uf pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study显示文摘Bible K C Suman V J Molina J R 2010Lancet Oncol2010,11,10:1
19Implant contamination duringspine surgery 显示文摘Bible J E O'Neill K R Crosby C G 2013Spine J2013,13,63:1
20Genetic evolu- tion of enterovirus 71 : epidemiological and pathological impli- cations 显示文摘BIBLE J M PANTELIDIS P CHAN P K 2007Rev Med Viro12007,17,6:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费